Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Molecular Imaging in Radiation Oncology - Brief Introduction for Physicists Yoichi Watanabe, Ph.D. Department of Radiation Oncology [email protected] AAPM Working Group of Molecular Imaging in Radiation Oncology (WGMIR) DISCLOSURE • Nothing to disclose Outline 1. Definition of molecular imaging (MI) 2. Brief review of molecular biology 3. Examples of MI techniques 4. Applications of MI in radiation oncology What is “Molecular Imaging?” Definition by SNM/RSNA “Molecular Imaging (MI) techniques directly or indirectly monitor and record the spatiotemporal distribution of molecular or cellular processes for biochemical, biologic, diagnostic, or therapeutic applications.” Thakur, ML et al., J Nucl Med 46(9):11N-13N (2005) History of Imaging Tools Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452(7187):580-9 Cell, Genome, DNA, Genotype, and Phenotype Cytoplasm Cell membrane Nucleus Nuclear membrane Chromosome/Chromatin Cytosol Weissleder R, Mahmood U Radiology 2001;219:316-333 Molecular Constituents in Cell Water 18 Da Glucose 180 Da Amino acid ~110 Da Protein ~100 kDa DNA base pair ~ 650 Da RNA 100 to 200 kDa DNA 2.1x1012 Da Molecular Species Number per Cell Endogenous or Exogenous DNA (3 billions base-pairs) 23 chromosomes Endogenous messenger RNA (mRNA) 50 – 1,000 Endogenous Protein 102 - 106 Endogenous Protein Function “Unlimited” Through amplification Cell Cycle Mitosis or Apoptosis Checkpoint Apoptosis Damaged cells are repaired. R.Weinberg, Sci Amer. (1996) Checkpoint Growth Factor and Receptor EGF EGFReceptor R.A.Weinberg, Sci Am (1996) The Hallmarks of Cancer Proliferation Vasculature Hypoxia Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. Metastasis Which biology to image with Molecular Imaging? Selection of “imaging biomarker” Cell proliferation (or Apoptosis) Angiogenesis (or vascular density) • Metabolism • Microenvironment (or Hypoxia) • Proteins Gene expression (gene proteins) [18F] FDG PET-CT Siemens biograph [18F] FDG: (Fluorodeoxyglucose F18) 2-deoxy-2-[18F]fluoro-D-glucose, C6H1118FO5. • • • Each ml of solution contains between 0.37 to 3.7 GBq (10.0 - 100 mCi) of FDG, 4.5 mg of sodium chloride and 7.2 mg of citrate ions. The pH of the solution is between 5.0 to 7.5. The recommended dose of [F-18]FDG injection for an adult (70 kg) is 185-370 MBq (5-10 mCi) as an intravenous injection for studies of malignancy, cardiology and epilepsy. Tumor cells are metabolically active; so glucose (e.g. FDGPET) accumulates in the tumor cells. Glucose Metabolism: Glycolysis Takes place in cytosol in a cell Produces 2 ATP Produces 2 NADH Produces 2 pyruvates Generates energy No oxygen is needed Alberts et al, Mol Biol of Cell 5th (2008) [18F] Fluorothymidine (FLT) • 18F-3’-deoxy-3’-fluorothymidine. • FLT accumulates in dividing cells. • FLT uptake is positively correlated with cell growth and TK1 activity. Buck AK, et al., Journal of Nuclear Medicine. 2003;44(9):1426-31. DNA Synthesis Pathways Radiolabeled Thymidine (FLT) DNA synthesis pathways. James R. Bading, and Anthony F. Shields J Nucl Med 2008;49:64S-80S Courtesy of Kiaran McGee, Ph.D. Hyperpolarized MRI • Hyperpolarized 13C-pyruvate. • Can study metabolic and catabolic pathways. K.Colman and J.S.Peterson,, Acad radiol 2006; 13:932 X-ray CT Enhanced photon attenuation: Anti-EGFR conjugated gold nanoparticles implanted in human squamous cell carcinoma T. Reuveni, et al., International journal of nanomedicine 6, 2859-2864 (2011). Ultrasound: Angiogenesis Microbubbles (MB) were conjugated to cyclic peptides containing either tripeptide arginine-arginine-leucine RRL (RRL-MB) or a glycine control sequence (control-MB). (A) background-subtracted, color-coded ultrasound image taken 120 seconds after injection of MBs conjugated to RRL (RRL-MB) into a mouse bearing a Clone C tumor. (B) Control. (C) Images of a mouse with a PC3 tumor. (D) Control (E) -(G) photomicrographs (H),(I) normal myocardium Weller, G. E.R. et al. Cancer Res 2005;65:533-539 Molecular Imaging in Radiation Oncology 1. Molecular signature determination (molecular characteristics of tumor) 2. Monitoring the efficacy of therapy or assessing treatment response 3. Molecular therapeutics FDG-PET for Target Delineation (an example of geographic miss) (Left) PET image coregistered with CT. (Right) Treatment plan for the target drawn only using CT. Only 70% of PTVPET/CT receives at least 90% of prescribed dose. Mah, K. et al., IJROBP 52:339 (2002) FLT-PET for Therapy Monitoring Treatment plan Day 8 Day 29 Everitt S, et al., Int J Radiat Oncol Biol Phys. 2009. doi:S0360-3016 Difficulty of Image Registration • CT-CT, CT-MRI, CT-PET, CT-MRI, MRIPET, etc.. • Rigid image registration • Deformable registration CT-PET scanner Uncertainty in Target Definition GTV40 GTV2.5 PET Planning CT SUVmax=30 red GTV40, green GTVbg, yellow GTVCT “The different techniques of tumor contour definition by 18F-FDG PET in radiotherapy planning lead to substantially different volumes, especially in patients with inhomogeneous tumors. “ Nestle, U. et al. J. Nucl Med 46:1342 (2005) AAPM Task Group 211 “Classification, Advantages and Limitations of the Numerical Lesion Segmentation Approaches for PET” Charge: To study the advantages, the limitation, and the applicability of proposed PET-Automatic Segmentation (AS) methods. The TG report due in 2016 lists 24 PET-AS methods. Conclusion: The more sophisticated the method, the better. But, there is no winner! TG group chair: A.Kirov, Ph.D. Summary • Molecular imaging (MI) is used to provide clinically valuable information on the biological status of the tumor. • MI technology is evolving and more MI tools are on the way to our clinics. Medical physicists need to understand underling biological mechanisms to effectively utilize the MI tools in clinics. References Pysz M A, Gambhir S S, and Willmann J K 2010 Molecular imaging: current status and emerging strategies Clinical Radiology 65 500-16. Munley M.T., Kagadis G.C., McGee K.P., et al., 2013 An introduction to molecular imaging in radiation oncology: A report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR), Medical Physics 40, 101501. Schober O. and Riemann B., ed. 2013 Molecular Imaging in Oncology. Recent Results in Cancer Research. Vol. 187. 2013, (Springer-Verlag, Berlin Heidelberg). Luna J. C., Vilanova J., Celso Hygino da Cruze L and Rossi S.E., ed. 2014 Functional Imaging in Oncology: Biophysical Basis and Technical Approaches, Vol. 1, (Springer-Verlag, Berlin Heidelberg). Benfey, P.N., Quickstart Molecular Biology: An Introductory Course for Mathematicians, Physicists, and Engineers. 2014, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. (160 pages)